- Presentations
- 5
- Markets
- 1
Matzim LA is a brand of Diltiazem marketed by Actavis Pharma, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Diltiazem
- Brand owner
- Actavis Pharma
- Registered in
- United States
- Strengths and forms
- 180 mg extended-release tablet, 240 mg extended-release tablet, 300 mg extended-release tablet, 360 mg extended-release tablet, 420 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Matzim LA 180 mg extended-release tabletOral | Actavis Pharma | US FDA | Available on request |
| Matzim LA 240 mg extended-release tabletOral | Actavis Pharma | US FDA | Available on request |
| Matzim LA 300 mg extended-release tabletOral | Actavis Pharma | US FDA | Available on request |
| Matzim LA 360 mg extended-release tabletOral | Actavis Pharma | US FDA | Available on request |
| Matzim LA 420 mg extended-release tabletOral | Actavis Pharma | US FDA | Available on request |
Equivalent brands
Other brands of Diltiazem.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Matzim LA
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.